- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03908879
Intraosseous Catheter Confirmation Study
September 6, 2023 updated by: Yonatan Greenstein, MD, Rutgers, The State University of New Jersey
Prospective Diagnostic Accuracy Study Comparing Sensitivity and Specificity of Methods Used to Confirm Correct Placement of an Intraosseous (IO) Catheter
This is a prospective diagnostic accuracy study investigating the sensitivity and specificity of methods used to confirm correct placement of an intraosseous (IO) catheter.
Intraosseous catheters allow medical providers to rapidly administer fluids and medications to critically ill patients when intravenous (IV) access is not present or difficult to achieve.
It is standard of care to confirm the correct placement of an IO catheter prior to using it to administer medications or fluids.
Three IO placement confirmatory tests will be performed on all research subjects using a standardized protocol.
There will be two index tests (the method utilized by most of the medical community evaluating the stability of the catheter, ability to aspirate blood or bone marrow and ability to administer fluids without visible or palpable extravasation as well as the method of demonstrating color flow Doppler only within the intraosseous space during bedside ultrasound exam) and one reference test (ability to visualized a pulsatile waveform when the IO catheter is attached to a pressure transducer).
Primary outcome measures of the study will be the determination of correct or incorrect IO catheter placement from the confirmation methods.
This data will be used to investigate the primary endpoints of sensitivity and specificity of the confirmation tests as well as inter-operator variability interpreting the raw data from the confirmation methods.
Secondary outcomes include complications from the IO catheter.
The goal of this study is to see if a more sensitive and specific method of IO catheter confirmation can reliably be performed by different physicians and reduce the amount of complications associated with the catheters.
Additional subgroup analyses will be performed in regards to the research subjects BMI and the anatomic site selected for IO catheter use (proximal tibia or humeral head).
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07103
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients greater than 18 years of age
- Full code
- Require placement of an intraosseous catheter for emergent resuscitation due to lack of reliable intravenous access
- Capable of undergoing all three intraosseous placement confirmatory methods
Exclusion Criteria:
- Age less than 18 years old
- Pregnant patients
- Prisoner/incarcerated
- Patients unable to undergo all three intraosseous placement confirmatory methods
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intraosseous (IO) catheter placement confirmation methods
All patients will undergo all three confirmation methods/procedures.
Method 1 is a triage test and an index test.
Method 2 is an index test.
Method 3 is a reference standard.
None of the procedures being performed in this study are regulated by the United States Food and Drug Administration.
|
The physician will evaluate the ability or inability of the intraosseous (IO) catheter to stand upright unassisted, the ability or inability to aspirate blood or bone marrow from the IO catheter, and whether or not there is visible or palpable extravasation of infusate from the IO catheter insertion site or surrounding subcutaneous tissue during IO catheter use.
Other Names:
The high frequency probe of a portable ultrasound with color flow Doppler is placed adjacent to the intraosseous (IO) catheter, visualizing the IO space in long or short axis.
Color flow Doppler signal will be turned on during IO use and the physician will determine if the Doppler signal is in the intraosseous space or the extraosseous space.
Saved data of the ultrasound image will be reviewed independently by at least two blinded reviewers.
If the conclusions from the blinded reviewers are discordant then a third blinded reviewer will evaluate the saved data.
Other Names:
The intraosseous (IO) catheter will be attached to a pressure transducer to demonstrate a waveform on the telemetry monitor.
Physicians will evaluate for the presence of a pulsatile waveform with objective measurements of a systolic pressure, diastolic pressure and mean pressure.
Saved data of the waveform image will be reviewed independently by at least two blinded reviewers.
If the conclusions from the blinded reviewers are discordant then a third blinded reviewer will evaluate the saved data.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Categorical determination of correct IO catheter placement by physicians placing the catheter
Time Frame: Within 24 hours of intraosseous (IO) catheter insertion
|
Categorical determination (yes/no) regarding correct IO catheter placement in the intraosseous space of all three confirmatory methods from the physicians placing the IO catheter
|
Within 24 hours of intraosseous (IO) catheter insertion
|
|
Categorical determination of correct IO catheter placement by blinded reviewers
Time Frame: Within 1 week of ultrasound images and pressure transduction images being created by the physician placing the IO catheter
|
Categorical determination (yes/no) regarding correct IO catheter placement in the intraosseous space for method 2 and method 3 by the blinded reviewers
|
Within 1 week of ultrasound images and pressure transduction images being created by the physician placing the IO catheter
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
IO catheter pressure
Time Frame: Within 24 hours of intraosseous (IO) catheter insertion
|
Pressures measured from transducing the IO catheter: systolic pressure, diastolic pressure, mean pressure
|
Within 24 hours of intraosseous (IO) catheter insertion
|
|
Systemic blood pressure
Time Frame: Within 24 hours of intraosseous (IO) catheter insertion
|
Pressures measured from a noninvasive blood pressure cuff or an arterial line: systolic pressure diastolic pressure mean pressure
|
Within 24 hours of intraosseous (IO) catheter insertion
|
|
Number of attempts to place IO catheter
Time Frame: Within 24 hours of intraosseous (IO) catheter insertion
|
Number of attempts made to place an IO catheter
|
Within 24 hours of intraosseous (IO) catheter insertion
|
|
Complications related to IO catheter
Time Frame: Within 28 days of IO catheter insertion
|
Complications associated with the IO catheter after insertion
|
Within 28 days of IO catheter insertion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yonatan Greenstein, MD, Rutgers, The State University of New Jersey
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Stone MB, Teismann NA, Wang R. Ultrasonographic confirmation of intraosseous needle placement in an adult unembalmed cadaver model. Ann Emerg Med. 2007 Apr;49(4):515-9. doi: 10.1016/j.annemergmed.2006.11.009. Epub 2007 Jan 12.
- Tsung JW, Blaivas M, Stone MB. Feasibility of point-of-care colour Doppler ultrasound confirmation of intraosseous needle placement during resuscitation. Resuscitation. 2009 Jun;80(6):665-8. doi: 10.1016/j.resuscitation.2009.03.009. Epub 2009 Apr 22.
- Frascone RJ, Salzman JG, Ernest EV, Burnett AM. Use of an intraosseous device for invasive pressure monitoring in the ED. Am J Emerg Med. 2014 Jun;32(6):692.e3-4. doi: 10.1016/j.ajem.2013.12.029. Epub 2013 Dec 18.
- Salzman JG, Loken NM, Wewerka SS, Burnett AM, Zagar AE, Griffith KR, Bliss PL, Peterson BK, Ward CJ, Frascone RJ. Intraosseous Pressure Monitoring in Healthy Volunteers. Prehosp Emerg Care. 2017 Sep-Oct;21(5):567-574. doi: 10.1080/10903127.2017.1302529. Epub 2017 Apr 18.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 23, 2019
Primary Completion (Actual)
May 1, 2022
Study Completion (Actual)
May 1, 2022
Study Registration Dates
First Submitted
April 4, 2019
First Submitted That Met QC Criteria
April 8, 2019
First Posted (Actual)
April 9, 2019
Study Record Updates
Last Update Posted (Actual)
September 8, 2023
Last Update Submitted That Met QC Criteria
September 6, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro2019000600
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Istanbul Medeniyet UniversityRecruiting
Clinical Trials on Standard intraosseous (IO) catheter confirmation procedure
-
Lazarski UniversityPoznan University of Medical Sciences; Wroclaw Medical University; Medical University...CompletedShock | Emergency Medicine | Cardiopulmonary ArrestPoland
-
The Methodist Hospital Research InstituteActive, not recruiting
-
The Methodist Hospital Research InstituteNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedAtrial Fibrillation | Ventricular TachycardiaUnited States
-
Mayo ClinicRecruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis and Ureter Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v7 | Refractory Bladder Urothelial Carcinoma | Refractory Renal Pelvis and Ureter Urothelial Carcinoma | Stage IV Renal Pelvis and Ureter Cancer AJCC v7United States